uric acid has been researched along with Fatty Liver in 107 studies
Uric Acid: An oxidation product, via XANTHINE OXIDASE, of oxypurines such as XANTHINE and HYPOXANTHINE. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals URATE OXIDASE further oxidizes it to ALLANTOIN.
uric acid : An oxopurine that is the final oxidation product of purine metabolism.
6-hydroxy-1H-purine-2,8(7H,9H)-dione : A tautomer of uric acid having oxo groups at C-2 and C-8 and a hydroxy group at C-6.
7,9-dihydro-1H-purine-2,6,8(3H)-trione : An oxopurine in which the purine ring is substituted by oxo groups at positions 2, 6, and 8.
Fatty Liver: Lipid infiltration of the hepatic parenchymal cells resulting in a yellow-colored liver. The abnormal lipid accumulation is usually in the form of TRIGLYCERIDES, either as a single large droplet or multiple small droplets. Fatty liver is caused by an imbalance in the metabolism of FATTY ACIDS.
| Excerpt | Relevance | Reference |
|---|---|---|
| " For many years, hyperuricemia was attributed to the effects of insulin resistance to reduce urinary excretion of uric acid, and it was believed that uric acid may not have any causal role in the metabolic syndrome." | 8.98 | Uric Acid as a Cause of the Metabolic Syndrome. ( Jensen, T; Johnson, RJ; King, C; Lanaspa, MA; Sánchez-Lozada, LG; Tolan, DR, 2018) |
| "Uric acid regulates hepatic steatosis and insulin resistance through the NLRP3 inflammasome." | 7.83 | Uric acid regulates hepatic steatosis and insulin resistance through the NLRP3 inflammasome-dependent mechanism. ( He, H; Li, D; Li, Y; Lin, Y; Liu, X; Lu, C; Sang, J; Wan, X; Xu, C; Yu, C, 2016) |
| " After adjusting for demographics, hypertension, waist circumference, triglycerides, high-density lipoprotein-cholesterol, homeostasis model assessment-estimated insulin resistance, estimated glomerular filtration rate, and aspartate aminotransferase, uric acid (4th quartile) was significantly associated with NAFLD (odds ratio 1." | 7.79 | Elevated serum uric acid levels are associated with non-alcoholic fatty liver disease independently of metabolic syndrome features in the United States: Liver ultrasound data from the National Health and Nutrition Examination Survey. ( Chonchol, M; Jalal, DI; Johnson, RJ; McFann, K; Sirota, JC; Targher, G, 2013) |
| "Increased serum uric acid (SUA) levels may be involved in the development of non-alcoholic fatty liver disease (NAFLD) in men presenting with metabolic syndrome (MetS) and/or insulin resistance." | 7.79 | Serum uric acid and non-alcoholic fatty liver disease in non-diabetic Chinese men. ( Gao, Y; Hu, Y; Huang, Z; Li, L; Li, Z; Liang, Z; Liao, M; Lu, Z; Mo, Z; Peng, T; Qin, X; Shi, D; Sun, Y; Tan, A; Wang, M; Wu, C; Xie, Y; Yang, X; Zhang, H; Zhang, S; Zhang, Y, 2013) |
| "The aim of this study was to compare serum uric acid values in two ethnically distinct Chinese populations: Uyghur, with a high prevalence of nonalcoholic fatty liver disease, and Han, with a lower prevalence." | 7.79 | Serum uric acid levels and non-alcoholic fatty liver disease in Uyghur and Han ethnic groups in northwestern China. ( Cai, W; Miao, L; Sun, YP; Wu, X; Yao, H; Zhang, B; Zou, Y, 2013) |
| "Uric acid is an independent risk factor in fructose-induced fatty liver, but whether it is a marker or a cause remains unknown." | 7.78 | Uric acid induces hepatic steatosis by generation of mitochondrial oxidative stress: potential role in fructose-dependent and -independent fatty liver. ( Choi, YJ; Cicerchi, C; Duranay, M; Ishimoto, T; Johnson, RJ; Kanbay, M; Kang, DH; Lanaspa, MA; Li, N; Marek, G; Nakagawa, T; Rodriguez-Iturbe, B; Roncal-Jimenez, CA; Sanchez-Lozada, LG; Sautin, YY; Schreiner, G, 2012) |
| "The objective of the study was to assess the prospective association between serum uric acid levels and incident nonalcoholic fatty liver disease in a cohort of healthy Korean men." | 7.77 | Serum uric acid levels predict incident nonalcoholic fatty liver disease in healthy Korean men. ( Chang, Y; Cho, J; Guallar, E; Kim, SG; Ryu, S, 2011) |
| "The objective of the present study was to determine the relationship between serum uric acid (SUA) level and the presence of nonalcoholic fatty liver disease (NAFLD)." | 7.77 | The relationship between normal serum uric acid and nonalcoholic fatty liver disease. ( Ahn, HY; Hwang, IC; Suh, AR; Suh, SY, 2011) |
| "Nonalcoholic fatty liver disease (NAFLD) is a common form of chronic liver disease, and serum uric acid is observed to be significantly elevated in NAFLD patients." | 7.76 | High serum uric acid increases the risk for nonalcoholic Fatty liver disease: a prospective observational study. ( Li, Y; Miao, M; Xu, C; Xu, L; Yu, C, 2010) |
| "Increased uric acid is associated with the metabolic syndrome, conditions linked to oxidative stress and insulin resistance." | 7.76 | Association between serum uric acid and non-alcoholic fatty liver disease in Korean adults. ( Lee, HR; Lee, JH; Lee, YJ; Shim, JY; Shin, YH, 2010) |
| "Serum uric acid level has been suggested to be associated with factors that contribute to the metabolic syndrome." | 7.75 | Association of serum uric acid level with non-alcoholic fatty liver disease: a cross-sectional study. ( Li, Y; Miao, M; Xu, C; Xu, L; Yu, C, 2009) |
| "Fasting insulin and serum uric acid levels indicating insulin resistance, but not indices of iron overload, are independent predictors of non-alcoholic fatty liver disease." | 7.71 | Fasting insulin and uric acid levels but not indices of iron metabolism are independent predictors of non-alcoholic fatty liver disease. A case-control study. ( Bagni, A; Bertolotti, M; Borsatti, A; Carulli, N; Ganazzi, D; Leonardi, F; Lonardo, A; Loria, P; Neri, P; Pulvirenti, M; Verrone, AM, 2002) |
| "We investigated the relationship between the concentration of circulating leptin and fatty liver by measuring the serum concentration of leptin in 284 male students who received the matriculation health examination in Okayama University in 1996 (n = 197; age, 18-20 yr) or 1997 (n = 87; age, 18-20 yr)." | 7.70 | Relationship between serum leptin and fatty liver in Japanese male adolescent university students. ( Higashi, T; Imai, A; Iwasaki, Y; Matsuura, K; Ogura, T; Shimomura, H; Tobe, K; Tsuji, T; Tsukamoto, C, 1999) |
| "Allopurinol is an inhibitor of xanthine oxidoreductase (XOR) and inhibits the generation of uric acid (UA) as the final product of purine catabolism, as well as the resulting generation of superoxide (O2(-)), in humans." | 6.45 | Allopurinol, an inhibitor of uric acid synthesis--can it be used for the treatment of metabolic syndrome and related disorders? ( Nozaki, S; Onuma, M; Suzuki, I; Yamauchi, T, 2009) |
| "Uric acid is an endogenous danger signal and activator of the inflammasome, and has been independently associated with an increased risk of cirrhosis." | 5.51 | Higher levels of serum uric acid influences hepatic damage in patients with non-alcoholic fatty liver disease (NAFLD). ( Aller, R; Ampuero, J; Andrade, RJ; Aspichueta, P; Buque, X; Burgos-Santamaría, D; Fernández Rodríguez, CM; Gómez-Camarero, J; Gutiérrez García, ML; Hernández-Guerra, M; Latorre, M; Martín-Mateos, RMª; Romero-Gómez, M; Rosales, JM, 2019) |
| "Nonalcoholic fatty liver disease (NAFLD) is an emerging health problem worldwide." | 5.39 | Relationship between serum uric acid level and nonalcoholic fatty liver disease in pre- and postmenopausal women. ( Moon, SS, 2013) |
| "Addition of fructose to the diet of normal weight and overweight subjects can increase postprandial plasma triglyceride and uric acid concentration." | 5.24 | Metabolic Effects of Replacing Sugar-Sweetened Beverages with Artificially-Sweetened Beverages in Overweight Subjects with or without Hepatic Steatosis: A Randomized Control Clinical Trial. ( Boesch, C; Brandejsky, V; Campos, V; Despland, C; Kreis, R; Schneiter, P; Tappy, L, 2017) |
| " vulgaris extract to the therapeutic regimen of NAFLD including metformin and vitamin E, is associated with favorable effects on serum levels of transaminases, triglycerides as well as insulin sensitivity." | 5.16 | Investigation of the effects of Chlorella vulgaris supplementation in patients with non-alcoholic fatty liver disease: a randomized clinical trial. ( Beiraghdar, F; Ghamarchehreh, ME; Jalalian, HR; Panahi, Y; Sahebkar, A; Zare, R, 2012) |
| " For many years, hyperuricemia was attributed to the effects of insulin resistance to reduce urinary excretion of uric acid, and it was believed that uric acid may not have any causal role in the metabolic syndrome." | 4.98 | Uric Acid as a Cause of the Metabolic Syndrome. ( Jensen, T; Johnson, RJ; King, C; Lanaspa, MA; Sánchez-Lozada, LG; Tolan, DR, 2018) |
| "Both elevated levels of uric acid and non-alcoholic fatty liver disease (NAFLD) have been associated with increased vascular risk." | 4.87 | Hyperuricaemia and non-alcoholic fatty liver disease (NAFLD): a relationship with implications for vascular risk? ( Athyros, VG; Karagiannis, A; Katsiki, N; Mikhailidis, DP, 2011) |
| " Laboratory tests revealed liver dysfunction, coagulopathy, hypoglycemia, hypoproteinemia, leukocytosis, and elevated creatinine and uric acid levels." | 4.12 | Timely identification and successful treatment of acute fatty liver of pregnancy without obvious clinical symptoms: Case reports. ( Cao, W; Chen, T; Geng, Y; Jiang, W; Wang, Q; Wang, X; Xie, B, 2022) |
| "001), fibroblast growth factor 21, homeostasis model assessment of insulin resistance as an insulin resistance index and uric acid, and was negatively correlated with levels of high-density lipoprotein cholesterol and adiponectin." | 4.12 | Circulating level of fatty acid-binding protein 4 is an independent predictor of metabolic dysfunction-associated fatty liver disease in middle-aged and elderly individuals. ( Furuhashi, M; Higashiura, Y; Koyama, M; Ohnishi, H; Saitoh, S; Sakai, A; Shimamoto, K; Takahashi, S; Tanaka, M, 2022) |
| "High serum uric acid levels increase the risk of liver steatosis in lean patients." | 3.96 | Hepatic Steatosis in Lean Patients: Risk Factors and Impact on Mortality. ( Eigenbauer, E; Forstner, B; Mandorfer, M; Muckenhuber, M; Paternostro, R; Pfisterer, N; Reiberger, T; Scheiner, B; Scheuba, K; Trauner, M; Unger, LW, 2020) |
| "High-dose exenatide treatment can effectively reduce body mass of obese mice, but it has little difference when compared with dietary intervention in improving blood fat and liver steatosis." | 3.85 | [The Preliminary Investigation of GLP-1 Receptor Agonist on Liver Steatosis in Obese Mice]. ( An, ZM; He, H; Huang, HJ; Li, SQ; Li, SY; Liang, LB; Wang, X; Zhang, M, 2017) |
| "Uric acid regulates hepatic steatosis and insulin resistance through the NLRP3 inflammasome." | 3.83 | Uric acid regulates hepatic steatosis and insulin resistance through the NLRP3 inflammasome-dependent mechanism. ( He, H; Li, D; Li, Y; Lin, Y; Liu, X; Lu, C; Sang, J; Wan, X; Xu, C; Yu, C, 2016) |
| " Variables included were waist circumference (WC), glucose, high-density lipoprotein (HDL), triglycerides (TGL), blood pressure, insulin resistance (by homeostatic model assessment HOMA-index), acanthosis nigricans (AN), uric acid, serum glutamic oxaloacetic transaminase (GOT) and alanine transaminase, and hepatic sonogram." | 3.83 | Models Predictive of Metabolic Syndrome Components in Obese Pediatric Patients. ( Barrera-de Leon, JC; Colunga Rodríguez, C; Hurtado López, EF; López Beltrán, AL; Ortega-Cortes, R; Tlacuilo-Parra, A; Trujillo, X, 2016) |
| "Serum uric acid levels are significantly associated with nonalcoholic fatty liver disease (NAFLD)." | 3.80 | The significance of serum xanthine oxidoreductase in patients with nonalcoholic fatty liver disease. ( Chen, Y; Xu, C; Zhang, J; Zhao, Y, 2014) |
| "Serum uric acid levels have been reported to be associated with non-alcoholic fatty liver disease (NAFLD)." | 3.80 | Relationship between serum uric acid levels and hepatic steatosis in non-obese postmenopausal women. ( Chen, Y; Liu, PJ; Lou, HP; Ma, F; Zhu, YN, 2014) |
| "Increased serum uric acid (SUA) levels may be involved in the development of non-alcoholic fatty liver disease (NAFLD) in men presenting with metabolic syndrome (MetS) and/or insulin resistance." | 3.79 | Serum uric acid and non-alcoholic fatty liver disease in non-diabetic Chinese men. ( Gao, Y; Hu, Y; Huang, Z; Li, L; Li, Z; Liang, Z; Liao, M; Lu, Z; Mo, Z; Peng, T; Qin, X; Shi, D; Sun, Y; Tan, A; Wang, M; Wu, C; Xie, Y; Yang, X; Zhang, H; Zhang, S; Zhang, Y, 2013) |
| "The aim of this study was to compare serum uric acid values in two ethnically distinct Chinese populations: Uyghur, with a high prevalence of nonalcoholic fatty liver disease, and Han, with a lower prevalence." | 3.79 | Serum uric acid levels and non-alcoholic fatty liver disease in Uyghur and Han ethnic groups in northwestern China. ( Cai, W; Miao, L; Sun, YP; Wu, X; Yao, H; Zhang, B; Zou, Y, 2013) |
| " After adjusting for demographics, hypertension, waist circumference, triglycerides, high-density lipoprotein-cholesterol, homeostasis model assessment-estimated insulin resistance, estimated glomerular filtration rate, and aspartate aminotransferase, uric acid (4th quartile) was significantly associated with NAFLD (odds ratio 1." | 3.79 | Elevated serum uric acid levels are associated with non-alcoholic fatty liver disease independently of metabolic syndrome features in the United States: Liver ultrasound data from the National Health and Nutrition Examination Survey. ( Chonchol, M; Jalal, DI; Johnson, RJ; McFann, K; Sirota, JC; Targher, G, 2013) |
| "Several works observed a link between uric acid serum levels and clinical and histological features of nonalcoholic fatty liver disease." | 3.78 | Hyperuricaemia: another metabolic feature affecting the severity of chronic hepatitis because of HCV infection. ( Cabibi, D; Cammà, C; Craxì, A; Macaluso, FS; Marco, VD; Petta, S, 2012) |
| "Uric acid is an independent risk factor in fructose-induced fatty liver, but whether it is a marker or a cause remains unknown." | 3.78 | Uric acid induces hepatic steatosis by generation of mitochondrial oxidative stress: potential role in fructose-dependent and -independent fatty liver. ( Choi, YJ; Cicerchi, C; Duranay, M; Ishimoto, T; Johnson, RJ; Kanbay, M; Kang, DH; Lanaspa, MA; Li, N; Marek, G; Nakagawa, T; Rodriguez-Iturbe, B; Roncal-Jimenez, CA; Sanchez-Lozada, LG; Sautin, YY; Schreiner, G, 2012) |
| " In this line recent studies observed an independent link between higher uric acid serum levels and clinical diagnosis of non-alcoholic fatty liver disease (NAFLD)." | 3.77 | Hyperuricemia is associated with histological liver damage in patients with non-alcoholic fatty liver disease. ( Cabibi, D; Cammà, C; Craxì, A; Di Marco, V; Petta, S, 2011) |
| "The objective of the study was to assess the prospective association between serum uric acid levels and incident nonalcoholic fatty liver disease in a cohort of healthy Korean men." | 3.77 | Serum uric acid levels predict incident nonalcoholic fatty liver disease in healthy Korean men. ( Chang, Y; Cho, J; Guallar, E; Kim, SG; Ryu, S, 2011) |
| "The objective of the present study was to determine the relationship between serum uric acid (SUA) level and the presence of nonalcoholic fatty liver disease (NAFLD)." | 3.77 | The relationship between normal serum uric acid and nonalcoholic fatty liver disease. ( Ahn, HY; Hwang, IC; Suh, AR; Suh, SY, 2011) |
| "Increased uric acid is associated with the metabolic syndrome, conditions linked to oxidative stress and insulin resistance." | 3.76 | Association between serum uric acid and non-alcoholic fatty liver disease in Korean adults. ( Lee, HR; Lee, JH; Lee, YJ; Shim, JY; Shin, YH, 2010) |
| "Nonalcoholic fatty liver disease (NAFLD) is a common form of chronic liver disease, and serum uric acid is observed to be significantly elevated in NAFLD patients." | 3.76 | High serum uric acid increases the risk for nonalcoholic Fatty liver disease: a prospective observational study. ( Li, Y; Miao, M; Xu, C; Xu, L; Yu, C, 2010) |
| "Diets containing 30% of fructose either as free fructose and glucose, or as sucrose, induce metabolic syndrome, intrahepatic accumulation of uric acid and TGs, increased MCP-1 and TNF-alpha as well as fatty liver in rats." | 3.76 | Comparison of free fructose and glucose to sucrose in the ability to cause fatty liver. ( Abdelmalek, M; Johnson, RJ; Lan, HY; Le, M; Mu, W; Nakagawa, T; Reungjui, S; Roncal, C; Sánchez-Lozada, LG; Sautin, YY; Yu, X, 2010) |
| "Serum uric acid level has been suggested to be associated with factors that contribute to the metabolic syndrome." | 3.75 | Association of serum uric acid level with non-alcoholic fatty liver disease: a cross-sectional study. ( Li, Y; Miao, M; Xu, C; Xu, L; Yu, C, 2009) |
| "Fasting insulin and serum uric acid levels indicating insulin resistance, but not indices of iron overload, are independent predictors of non-alcoholic fatty liver disease." | 3.71 | Fasting insulin and uric acid levels but not indices of iron metabolism are independent predictors of non-alcoholic fatty liver disease. A case-control study. ( Bagni, A; Bertolotti, M; Borsatti, A; Carulli, N; Ganazzi, D; Leonardi, F; Lonardo, A; Loria, P; Neri, P; Pulvirenti, M; Verrone, AM, 2002) |
| "We investigated the relationship between the concentration of circulating leptin and fatty liver by measuring the serum concentration of leptin in 284 male students who received the matriculation health examination in Okayama University in 1996 (n = 197; age, 18-20 yr) or 1997 (n = 87; age, 18-20 yr)." | 3.70 | Relationship between serum leptin and fatty liver in Japanese male adolescent university students. ( Higashi, T; Imai, A; Iwasaki, Y; Matsuura, K; Ogura, T; Shimomura, H; Tobe, K; Tsuji, T; Tsukamoto, C, 1999) |
| "Although the systemic physiological alterations present in pre-eclampsia appear disparate and unrelated, four of them (endothelial cell hyperplasia and alterations in uric acid, calcium, and prostaglandin homeostasis) are demonstrated here to mimic closely the pattern of intracellular alterations caused by the activation of a G protein-associated receptor." | 3.69 | Pre-eclampsia: excessive activation of a G protein-associated receptor? ( Coffey, CG, 1995) |
| "Allopurinol is an inhibitor of xanthine oxidoreductase (XOR) and inhibits the generation of uric acid (UA) as the final product of purine catabolism, as well as the resulting generation of superoxide (O2(-)), in humans." | 2.45 | Allopurinol, an inhibitor of uric acid synthesis--can it be used for the treatment of metabolic syndrome and related disorders? ( Nozaki, S; Onuma, M; Suzuki, I; Yamauchi, T, 2009) |
| "Uric acid is an endogenous danger signal and activator of the inflammasome, and has been independently associated with an increased risk of cirrhosis." | 1.51 | Higher levels of serum uric acid influences hepatic damage in patients with non-alcoholic fatty liver disease (NAFLD). ( Aller, R; Ampuero, J; Andrade, RJ; Aspichueta, P; Buque, X; Burgos-Santamaría, D; Fernández Rodríguez, CM; Gómez-Camarero, J; Gutiérrez García, ML; Hernández-Guerra, M; Latorre, M; Martín-Mateos, RMª; Romero-Gómez, M; Rosales, JM, 2019) |
| "Uric acid nephrolithiasis is associated with an elevated visceral fat area in kidney stone formers." | 1.46 | Computerized Tomography Based Diagnosis of Visceral Obesity and Hepatic Steatosis is Associated with Low Urine pH. ( Calle, J; Monga, M; Patel, ND; Remer, EM; Ward, RD, 2017) |
| "In conclusion, NAFLD is a common clinical problem that places children at substantial risk for high blood pressure, which may often go undiagnosed." | 1.40 | Longitudinal assessment of high blood pressure in children with nonalcoholic fatty liver disease. ( Behling, C; Donithan, M; Hallinan, EK; Newton, KP; Schwimmer, JB; Tonascia, J; Xanthakos, SA; Zepeda, A, 2014) |
| "Nonalcoholic fatty liver disease (NAFLD) is an emerging health problem worldwide." | 1.39 | Relationship between serum uric acid level and nonalcoholic fatty liver disease in pre- and postmenopausal women. ( Moon, SS, 2013) |
| "Children with NAFLD have a diet that is insufficient in vitamin E and this may contribute to the pathophysiology of NAFLD." | 1.38 | Correlation of vitamin E, uric acid, and diet composition with histologic features of pediatric NAFLD. ( Belt, P; Colvin, R; Lavine, JE; Molleston, JP; Murray, KF; Rosenthal, P; Schwimmer, JB; Tonascia, J; Unalp, A; Vos, MB, 2012) |
| "Patients with NAFLD had significantly lower levels of serum-free thyroxine (FT4) than controls (11·12 ± 1·43 vs 11·58 ± 1·47 pmol/l; P < 0·001)." | 1.37 | Association between thyroid function and nonalcoholic fatty liver disease in euthyroid elderly Chinese. ( Li, Y; Miao, M; Xu, C; Xu, L; Yu, C, 2011) |
| " In addition, there was a dose-response relationship between SU and NAFLD in subjects with and without gout." | 1.36 | Gout and risk of non-alcoholic fatty liver disease. ( Chang, HC; Chen, HW; Chiu, CT; Hwang, JS; Ko, YS; Kuo, CF; Luo, SF; See, LC; Tseng, WY; Yu, KH, 2010) |
| "Insulin resistance was determined by using homeostasis model assessment (HOMA-IR)." | 1.34 | Ultrasonographic and biochemical evaluation of visceral obesity in obese women with non-alcoholic fatty liver disease. ( Akdag, B; Fenkci, S; Rota, S; Sabir, N, 2007) |
| "Insulin resistance is a risk factors for non-alcoholic fatty liver disease (NAFLD) and for gallstone disease (GD)." | 1.33 | Gallstone disease in non-alcoholic fatty liver: prevalence and associated factors. ( Bertolotti, M; Carulli, L; Carulli, N; D'Amico, R; Ganazzi, D; Lombardini, S; Lonardo, A; Loria, P; Rudilosso, A; Verrone, A, 2005) |
| "Furthermore, obesity is a well characterized insulin resistant condition that is often associated with hepatic steatosis." | 1.32 | Insulin sensitivity and hepatic steatosis in obese subjects with normal glucose tolerance. ( Muggeo, M; Venturi, C; Zamboni, C; Zoppini, G, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 29 (27.10) | 18.7374 |
| 1990's | 3 (2.80) | 18.2507 |
| 2000's | 10 (9.35) | 29.6817 |
| 2010's | 53 (49.53) | 24.3611 |
| 2020's | 12 (11.21) | 2.80 |
| Authors | Studies |
|---|---|
| Tanaka, M | 1 |
| Takahashi, S | 1 |
| Higashiura, Y | 1 |
| Sakai, A | 1 |
| Koyama, M | 1 |
| Saitoh, S | 1 |
| Shimamoto, K | 1 |
| Ohnishi, H | 1 |
| Furuhashi, M | 1 |
| Cao, W | 1 |
| Chen, T | 1 |
| Jiang, W | 1 |
| Geng, Y | 1 |
| Xie, B | 1 |
| Wang, Q | 1 |
| Wang, X | 3 |
| Qu, J | 1 |
| Dou, J | 1 |
| Wang, A | 1 |
| Liu, Y | 1 |
| Lin, L | 1 |
| Chen, K | 1 |
| Zang, L | 1 |
| Mu, Y | 1 |
| Duan, H | 1 |
| Zhang, R | 1 |
| Chen, X | 1 |
| Yu, G | 1 |
| Song, C | 1 |
| Jiang, Y | 1 |
| He, Y | 1 |
| Wan, H | 1 |
| Shen, J | 1 |
| Zeng, H | 1 |
| Tang, C | 1 |
| Lin, B | 1 |
| Yu, M | 1 |
| Wang, J | 1 |
| Chen, S | 1 |
| Yu, C | 5 |
| Wang, H | 1 |
| Ba, Y | 1 |
| Gao, X | 2 |
| Zhuo, J | 1 |
| Li, Y | 5 |
| Sun, J | 1 |
| Zhang, S | 2 |
| Unger, LW | 1 |
| Forstner, B | 1 |
| Muckenhuber, M | 1 |
| Scheuba, K | 1 |
| Eigenbauer, E | 1 |
| Scheiner, B | 1 |
| Pfisterer, N | 1 |
| Paternostro, R | 1 |
| Trauner, M | 1 |
| Mandorfer, M | 1 |
| Reiberger, T | 1 |
| Nishikawa, T | 1 |
| Nagata, N | 1 |
| Shimakami, T | 1 |
| Shirakura, T | 1 |
| Matsui, C | 1 |
| Ni, Y | 1 |
| Zhuge, F | 1 |
| Xu, L | 5 |
| Chen, G | 1 |
| Nagashimada, M | 1 |
| Yamashita, T | 2 |
| Sakai, Y | 1 |
| Mizukoshi, E | 1 |
| Honda, M | 1 |
| Kaneko, S | 1 |
| Ota, T | 1 |
| Li, H | 1 |
| Guo, M | 1 |
| An, Z | 1 |
| Meng, J | 1 |
| Jiang, J | 1 |
| Song, J | 1 |
| Wu, W | 1 |
| Matsushita, Y | 1 |
| Hasegawa, Y | 1 |
| Takebe, N | 1 |
| Onodera, K | 1 |
| Shozushima, M | 1 |
| Oda, T | 1 |
| Nagasawa, K | 1 |
| Honma, H | 1 |
| Nata, K | 1 |
| Sasaki, A | 1 |
| Ishigaki, Y | 1 |
| Mazzoli, A | 1 |
| Gatto, C | 1 |
| Crescenzo, R | 1 |
| Cigliano, L | 1 |
| Iossa, S | 1 |
| Zhang, J | 2 |
| Xu, J | 1 |
| Lin, X | 1 |
| Tang, F | 1 |
| Tan, L | 1 |
| Patel, ND | 1 |
| Ward, RD | 1 |
| Calle, J | 1 |
| Remer, EM | 1 |
| Monga, M | 1 |
| He, H | 2 |
| Liang, LB | 1 |
| Zhang, M | 1 |
| Li, SY | 1 |
| Li, SQ | 1 |
| An, ZM | 1 |
| Huang, HJ | 1 |
| King, C | 1 |
| Lanaspa, MA | 7 |
| Jensen, T | 2 |
| Tolan, DR | 1 |
| Sánchez-Lozada, LG | 8 |
| Johnson, RJ | 11 |
| Cicero, AFG | 1 |
| Gitto, S | 1 |
| Fogacci, F | 1 |
| Rosticci, M | 1 |
| Giovannini, M | 1 |
| D'Addato, S | 1 |
| Andreone, P | 1 |
| Borghi, C | 1 |
| Niwa, K | 1 |
| Hisatome, I | 1 |
| Kanbay, M | 2 |
| Andres-Hernando, A | 3 |
| Roncal-Jimenez, CA | 5 |
| Sato, Y | 1 |
| Garcia, G | 2 |
| Ohno, M | 1 |
| Kuwabara, M | 1 |
| Fernández Rodríguez, CM | 1 |
| Aller, R | 1 |
| Gutiérrez García, ML | 1 |
| Ampuero, J | 1 |
| Gómez-Camarero, J | 1 |
| Martín-Mateos, RMª | 1 |
| Burgos-Santamaría, D | 1 |
| Rosales, JM | 1 |
| Aspichueta, P | 1 |
| Buque, X | 1 |
| Latorre, M | 1 |
| Andrade, RJ | 1 |
| Hernández-Guerra, M | 1 |
| Romero-Gómez, M | 1 |
| Moon, SS | 1 |
| Bray, GA | 1 |
| Neuschwander-Tetri, BA | 1 |
| Xie, Y | 1 |
| Wang, M | 1 |
| Zhang, Y | 1 |
| Tan, A | 1 |
| Gao, Y | 1 |
| Liang, Z | 1 |
| Shi, D | 1 |
| Huang, Z | 1 |
| Zhang, H | 1 |
| Yang, X | 2 |
| Lu, Z | 1 |
| Wu, C | 1 |
| Liao, M | 1 |
| Sun, Y | 1 |
| Qin, X | 1 |
| Hu, Y | 1 |
| Li, L | 1 |
| Peng, T | 1 |
| Li, Z | 1 |
| Mo, Z | 1 |
| Morsy, MA | 1 |
| Ibrahim, MA | 1 |
| Abd-Elghany, MI | 1 |
| Nakagawa, T | 4 |
| Shafiu, M | 1 |
| Sundaram, S | 1 |
| Le, M | 3 |
| Ishimoto, T | 5 |
| Sautin, YY | 4 |
| Cai, W | 1 |
| Wu, X | 1 |
| Zhang, B | 1 |
| Miao, L | 1 |
| Sun, YP | 1 |
| Zou, Y | 1 |
| Yao, H | 1 |
| Liu, PJ | 1 |
| Ma, F | 1 |
| Lou, HP | 1 |
| Zhu, YN | 1 |
| Chen, Y | 2 |
| Choi, YJ | 2 |
| Shin, HS | 1 |
| Choi, HS | 1 |
| Park, JW | 1 |
| Jo, I | 1 |
| Oh, ES | 1 |
| Lee, KY | 1 |
| Lee, BH | 1 |
| Kang, DH | 2 |
| Xu, C | 6 |
| Zhao, Y | 1 |
| Uyanik, M | 1 |
| Sertoglu, E | 1 |
| Kayadibi, H | 1 |
| Schwimmer, JB | 2 |
| Zepeda, A | 1 |
| Newton, KP | 1 |
| Xanthakos, SA | 1 |
| Behling, C | 1 |
| Hallinan, EK | 1 |
| Donithan, M | 1 |
| Tonascia, J | 2 |
| Agilli, M | 1 |
| Aydin, FN | 1 |
| Wan, X | 1 |
| Lin, Y | 1 |
| Lu, C | 1 |
| Li, D | 1 |
| Sang, J | 1 |
| Liu, X | 1 |
| Ortega-Cortes, R | 1 |
| Trujillo, X | 1 |
| Hurtado López, EF | 1 |
| López Beltrán, AL | 1 |
| Colunga Rodríguez, C | 1 |
| Barrera-de Leon, JC | 1 |
| Tlacuilo-Parra, A | 1 |
| Ercin, CN | 1 |
| Gurel, H | 1 |
| Dogru, T | 2 |
| Gugliucci, A | 1 |
| Li, YY | 1 |
| Yu, Y | 1 |
| Wang, F | 1 |
| Zhang, HQ | 1 |
| Zhao, M | 1 |
| Liu, L | 1 |
| Gao, L | 1 |
| Zhao, JJ | 1 |
| Wei, TY | 1 |
| Wang, CC | 1 |
| Campos, V | 1 |
| Despland, C | 1 |
| Brandejsky, V | 1 |
| Kreis, R | 1 |
| Schneiter, P | 1 |
| Boesch, C | 1 |
| Tappy, L | 1 |
| Miao, M | 3 |
| Suzuki, I | 1 |
| Yamauchi, T | 1 |
| Onuma, M | 1 |
| Nozaki, S | 1 |
| Mu, W | 1 |
| Roncal, C | 1 |
| Abdelmalek, M | 1 |
| Reungjui, S | 1 |
| Lan, HY | 1 |
| Yu, X | 1 |
| Lee, YJ | 1 |
| Lee, HR | 1 |
| Lee, JH | 1 |
| Shin, YH | 1 |
| Shim, JY | 1 |
| Loomba, R | 1 |
| Rao, F | 1 |
| Zhang, L | 1 |
| Khandrika, S | 1 |
| Ziegler, MG | 1 |
| Brenner, DA | 1 |
| O'Connor, DT | 1 |
| Kuo, CF | 1 |
| Yu, KH | 1 |
| Luo, SF | 1 |
| Chiu, CT | 1 |
| Ko, YS | 1 |
| Hwang, JS | 1 |
| Tseng, WY | 1 |
| Chang, HC | 1 |
| Chen, HW | 1 |
| See, LC | 1 |
| Ji, HF | 1 |
| Shen, L | 1 |
| Xu, CF | 1 |
| Yu, CH | 1 |
| Sa, XY | 1 |
| Li, YM | 1 |
| Ryu, S | 1 |
| Chang, Y | 1 |
| Kim, SG | 1 |
| Cho, J | 1 |
| Guallar, E | 1 |
| Katsiki, N | 1 |
| Athyros, VG | 1 |
| Karagiannis, A | 1 |
| Mikhailidis, DP | 1 |
| Hwang, IC | 1 |
| Suh, SY | 1 |
| Suh, AR | 1 |
| Ahn, HY | 1 |
| Kim, JH | 2 |
| Kim, SY | 1 |
| Jung, ES | 1 |
| Jung, SW | 1 |
| Koo, JS | 1 |
| Yeon, JE | 1 |
| Kwon, SY | 1 |
| Lee, SW | 1 |
| Byun, KS | 1 |
| Lee, CH | 1 |
| Petta, S | 2 |
| Cammà, C | 2 |
| Cabibi, D | 2 |
| Di Marco, V | 1 |
| Craxì, A | 2 |
| Genc, H | 1 |
| Tapan, S | 1 |
| Bagci, S | 1 |
| White, JS | 1 |
| Vos, MB | 1 |
| Colvin, R | 1 |
| Belt, P | 1 |
| Molleston, JP | 1 |
| Murray, KF | 1 |
| Rosenthal, P | 1 |
| Unalp, A | 1 |
| Lavine, JE | 1 |
| Macaluso, FS | 1 |
| Marco, VD | 1 |
| Keenan, T | 1 |
| Blaha, MJ | 1 |
| Nasir, K | 1 |
| Silverman, MG | 1 |
| Tota-Maharaj, R | 1 |
| Carvalho, JA | 1 |
| Conceição, RD | 1 |
| Blumenthal, RS | 1 |
| Santos, RD | 1 |
| Kubes, P | 1 |
| Mehal, WZ | 1 |
| Xia, MF | 1 |
| Lin, HD | 1 |
| Li, XM | 1 |
| Yan, HM | 1 |
| Bian, H | 1 |
| Chang, XX | 1 |
| He, WY | 1 |
| Jeekel, J | 1 |
| Hofman, A | 1 |
| Cicerchi, C | 3 |
| Li, N | 3 |
| Marek, G | 1 |
| Duranay, M | 1 |
| Schreiner, G | 2 |
| Rodriguez-Iturbe, B | 2 |
| Sirota, JC | 1 |
| McFann, K | 1 |
| Targher, G | 1 |
| Chonchol, M | 1 |
| Jalal, DI | 1 |
| Garcia, GE | 1 |
| Thomas, JB | 1 |
| Rivard, CJ | 2 |
| Hunter, B | 2 |
| Thomas, J | 1 |
| Hodges, RS | 1 |
| Mant, CT | 1 |
| Panahi, Y | 1 |
| Ghamarchehreh, ME | 1 |
| Beiraghdar, F | 1 |
| Zare, R | 1 |
| Jalalian, HR | 1 |
| Sahebkar, A | 1 |
| Tapia, E | 1 |
| Cristóbal, M | 1 |
| García-Arroyo, FE | 1 |
| Soto, V | 1 |
| Monroy-Sánchez, F | 1 |
| Pacheco, U | 1 |
| Cruz-Robles, D | 1 |
| Madero, M | 1 |
| COLMAN, RW | 1 |
| SHEIN, HM | 1 |
| Isselbacher, KJ | 1 |
| Greenberger, NJ | 1 |
| GIULIANI, A | 1 |
| SAMMARTINO, V | 1 |
| Zhang, XY | 1 |
| Kuang, CB | 1 |
| Venturi, C | 1 |
| Zoppini, G | 1 |
| Zamboni, C | 1 |
| Muggeo, M | 1 |
| Loria, P | 2 |
| Lonardo, A | 2 |
| Lombardini, S | 1 |
| Carulli, L | 1 |
| Verrone, A | 1 |
| Ganazzi, D | 2 |
| Rudilosso, A | 1 |
| D'Amico, R | 1 |
| Bertolotti, M | 2 |
| Carulli, N | 2 |
| García-Ruiz, I | 1 |
| Rodríguez-Juan, C | 1 |
| Díaz-Sanjuan, T | 1 |
| del Hoyo, P | 1 |
| Colina, F | 1 |
| Muñoz-Yagüe, T | 1 |
| Solís-Herruzo, JA | 1 |
| Fenkci, S | 1 |
| Rota, S | 1 |
| Sabir, N | 1 |
| Akdag, B | 1 |
| Groen, J | 1 |
| Baba, T | 1 |
| Amasaki, Y | 1 |
| Soda, M | 1 |
| Hida, A | 1 |
| Imaizumi, M | 1 |
| Ichimaru, S | 1 |
| Nakashima, E | 1 |
| Seto, S | 1 |
| Yano, K | 1 |
| Akahoshi, M | 1 |
| Renger, F | 1 |
| Yamazaki, K | 1 |
| Murata, M | 1 |
| Coffey, CG | 1 |
| Tobe, K | 1 |
| Ogura, T | 1 |
| Tsukamoto, C | 1 |
| Imai, A | 1 |
| Matsuura, K | 1 |
| Iwasaki, Y | 1 |
| Shimomura, H | 1 |
| Higashi, T | 1 |
| Tsuji, T | 1 |
| Davail, S | 1 |
| Guy, G | 1 |
| André, J | 1 |
| Hermier, D | 1 |
| Hoo-Paris, R | 1 |
| Leonardi, F | 1 |
| Borsatti, A | 1 |
| Neri, P | 1 |
| Pulvirenti, M | 1 |
| Verrone, AM | 1 |
| Bagni, A | 1 |
| Henninces, D | 1 |
| Förster, H | 1 |
| Weiss, V | 1 |
| Lomessy, A | 1 |
| Kolenda, KD | 1 |
| Young, SR | 1 |
| Stoelting, RK | 1 |
| Peterson, C | 1 |
| Madura, JA | 1 |
| Lieber, CS | 2 |
| Hsiung, R | 1 |
| Hasselmann, M | 1 |
| Lutun, P | 1 |
| Gordji, M | 1 |
| Jaross, W | 1 |
| Hanefeld, M | 1 |
| Schentke, KU | 1 |
| Trübsbach, A | 1 |
| Stötzner, H | 1 |
| Leonhardt, W | 1 |
| Herrmann, V | 1 |
| Fuchs, R | 1 |
| Peschel, G | 1 |
| Scheffler, W | 1 |
| Sinclair, HM | 1 |
| Michelis, MF | 1 |
| Warms, PC | 1 |
| Fusco, RD | 1 |
| Davis, BB | 1 |
| Bannister, DW | 1 |
| Burns, AB | 1 |
| Evans, AJ | 1 |
| Martindale, L | 1 |
| O'Sullivan, WJ | 1 |
| Babucke, G | 1 |
| Mertz, DP | 6 |
| Nitsan, Z | 1 |
| Nir, I | 1 |
| Dror, Y | 1 |
| Bruckental, I | 1 |
| Manes, JL | 1 |
| Taylor, HB | 1 |
| Starkloff, GB | 1 |
| Baddeley, M | 1 |
| Henninges, D | 3 |
| Sulzberger, I | 1 |
| Klöpfer, M | 1 |
| Zaar, I | 1 |
| Klöpfer-Zaar, M | 1 |
| Thieme, G | 1 |
| Scheier, CA | 1 |
| Tremel, R | 1 |
| Pohl, W | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Genetic-specific Effects of Fructose on Liver Lipogenesis[NCT03783195] | 15 participants (Actual) | Interventional | 2019-01-25 | Completed | |||
| Allopurinol Versus Febuxostat: A New Approach for Management of Hepatic Steatosis in Metabolic-Associated Fatty Liver Disease[NCT05474560] | Phase 4 | 90 participants (Actual) | Interventional | 2022-01-01 | Completed | ||
| Effects of 4-month Therapy of Levothyroxine on Non-Alcoholic Fatty Liver Disease (NAFLD) and Diabetes Control in Diabetic Patients[NCT03281083] | Phase 2 | 29 participants (Actual) | Interventional | 2014-03-28 | Terminated (stopped due to Difficult recruitment and end of funding.) | ||
| Insulin Resistance in Nonalcoholic Fatty Liver Disease: A Case Control Study[NCT00637520] | 29 participants (Actual) | Observational | 2007-07-31 | Terminated | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
15 reviews available for uric acid and Fatty Liver
| Article | Year |
|---|---|
Uric Acid as a Cause of the Metabolic Syndrome.
Topics: AMP Deaminase; Animals; Diabetes Mellitus; Dietary Sugars; Fatty Liver; Fructose; Humans; Hypertensi | 2018 |
Energy and fructose from beverages sweetened with sugar or high-fructose corn syrup pose a health risk for some people.
Topics: Beverages; Diabetes Mellitus; Diet; Dietary Sucrose; Fatty Liver; Fructose; Glucose; Gout; Humans; L | 2013 |
Carbohydrate intake and nonalcoholic fatty liver disease.
Topics: Animals; Beverages; Clinical Trials as Topic; Dietary Carbohydrates; Fatty Liver; Fibrosis; Humans; | 2013 |
Sugar, uric acid, and the etiology of diabetes and obesity.
Topics: Animals; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Dietary Sucrose; Disease Models, Animal | 2013 |
Allopurinol, an inhibitor of uric acid synthesis--can it be used for the treatment of metabolic syndrome and related disorders?
Topics: Allopurinol; Enzyme Inhibitors; Fatty Liver; Humans; Liver Diseases; Metabolic Syndrome; Mucositis; | 2009 |
The effect of fructose on renal biology and disease.
Topics: Diabetes Mellitus; Diet; Dietary Carbohydrates; Fatty Liver; Female; Fructose; Humans; Hypertension; | 2010 |
Hyperuricaemia and non-alcoholic fatty liver disease (NAFLD): a relationship with implications for vascular risk?
Topics: Cardiovascular Diseases; Chronic Disease; Evidence-Based Medicine; Fatty Liver; Humans; Hyperuricemi | 2011 |
Sterile inflammation in the liver.
Topics: Acetaminophen; Adenosine Triphosphate; Caspase 1; Chemical and Drug Induced Liver Injury; Chemotaxis | 2012 |
METABOLIC EFFECTS OF ALCOHOL ON THE LIVER.
Topics: Alcoholism; Carbohydrate Metabolism; Catecholamines; Ethanol; Fatty Liver; Folic Acid; Gastrointesti | 1964 |
[Alcohol and the liver].
Topics: Acetaldehyde; Carbohydrate Metabolism; Enzyme Induction; Fatty Liver; gamma-Glutamyltransferase; Hep | 1981 |
[Complication of childhood obesity].
Topics: Body Mass Index; Cardiovascular Diseases; Child; Diabetes Mellitus, Type 2; Fatty Liver; Female; Hum | 1995 |
Alcohol and the liver: metabolism of ethanol, metabolic effects and pathogenesis of injury.
Topics: Acetaldehyde; Acetates; Alcohol Dehydrogenase; Alcohol Oxidoreductases; Alcoholism; Animals; Blood G | 1985 |
Nutritional aspects of alcohol consumption.
Topics: Alcoholism; Animals; Cholecalciferol; Choline Deficiency; Ethanol; Fatty Liver; Glutamates; Humans; | 1972 |
Metabolic effects produced by alcohol in the liver and other tissues.
Topics: Acetaldehyde; Acetates; Alcoholism; Coenzymes; Deficiency Diseases; Dietary Carbohydrates; Enzymes; | 1968 |
Orotic acid.
Topics: Allopurinol; Anemia, Pernicious; Animals; Azauridine; Carboxy-Lyases; Fatty Liver; Female; Humans; I | 1973 |
3 trials available for uric acid and Fatty Liver
| Article | Year |
|---|---|
Metabolic Effects of Replacing Sugar-Sweetened Beverages with Artificially-Sweetened Beverages in Overweight Subjects with or without Hepatic Steatosis: A Randomized Control Clinical Trial.
Topics: Adult; Blood Glucose; Body Mass Index; Diet; Fatty Acids, Nonesterified; Fatty Liver; Female; Glucag | 2017 |
Investigation of the effects of Chlorella vulgaris supplementation in patients with non-alcoholic fatty liver disease: a randomized clinical trial.
Topics: Adult; Aged; Alanine Transaminase; Alkaline Phosphatase; Antioxidants; Aspartate Aminotransferases; | 2012 |
[Clinical observation on treatment of nonalcoholic fatty liver disease complicating hyperuricemia by Zhifang I Decoction].
Topics: Adult; Aged; Alanine Transaminase; Drugs, Chinese Herbal; Fatty Liver; Female; gamma-Glutamyltransfe | 2004 |
89 other studies available for uric acid and Fatty Liver
| Article | Year |
|---|---|
Circulating level of fatty acid-binding protein 4 is an independent predictor of metabolic dysfunction-associated fatty liver disease in middle-aged and elderly individuals.
Topics: Adiponectin; Adult; Aged; Aged, 80 and over; Cholesterol, HDL; Diabetes Mellitus, Type 2; Fatty Acid | 2022 |
Timely identification and successful treatment of acute fatty liver of pregnancy without obvious clinical symptoms: Case reports.
Topics: Adult; Blood Coagulation Disorders; Fatty Liver; Female; Humans; Hypoglycemia; Infant, Newborn; Preg | 2022 |
Fatty liver index for hyperuricemia diagnosis: a community-based cohort study.
Topics: Adult; Cohort Studies; Fatty Liver; Humans; Hyperuricemia; Incidence; Uric Acid | 2022 |
Associations of Uric Acid With Liver Steatosis and Fibrosis Applying Vibration Controlled Transient Elastography in the United States: A Nationwide Cross-Section Study.
Topics: Cross-Sectional Studies; Elasticity Imaging Techniques; Fatty Liver; Female; Humans; Liver Cirrhosis | 2022 |
The regulation effect of GLUT9/SLC2A9 on intrahepatic uric acid level and metabolic associated fatty liver disease.
Topics: Animals; Fatty Acids; Fatty Liver; Genotype; Glucose Transport Proteins, Facilitative; Humans; Male; | 2022 |
Association between serum uric acid to high density lipoprotein-cholesterol ratio and arterial stiffness in a Japanese population.
Topics: Adult; Aged; Aged, 80 and over; Ankle Brachial Index; Cholesterol, HDL; Disease Progression; East As | 2023 |
Hepatic Steatosis in Lean Patients: Risk Factors and Impact on Mortality.
Topics: Adult; Body Mass Index; Elasticity Imaging Techniques; Fatty Liver; Female; Humans; Hyperuricemia; L | 2020 |
Xanthine oxidase inhibition attenuates insulin resistance and diet-induced steatohepatitis in mice.
Topics: Allopurinol; Animals; Diet, High-Fat; Disease Models, Animal; Fatty Liver; Febuxostat; Hyperuricemia | 2020 |
Prevalence and Risk Factors of Metabolic Associated Fatty Liver Disease in Xinxiang, China.
Topics: Adult; Aged; Blood Glucose; Body Mass Index; China; Cross-Sectional Studies; Fatty Liver; Female; He | 2020 |
Serum C-X-C motif chemokine ligand 14 levels are associated with serum C-peptide and fatty liver index in type 2 diabetes mellitus patients.
Topics: Adiponectin; Age Factors; Aged; Alanine Transaminase; Biomarkers; Body Mass Index; C-Peptide; Chemok | 2021 |
Prolonged Changes in Hepatic Mitochondrial Activity and Insulin Sensitivity by High Fructose Intake in Adolescent Rats.
Topics: Alanine Transaminase; Animals; Body Composition; Ceramides; Diet, Carbohydrate Loading; Disease Mode | 2021 |
CTRP3 ameliorates fructose-induced metabolic associated fatty liver disease via inhibition of xanthine oxidase-associated oxidative stress.
Topics: Adipokines; Animals; Fatty Acid Synthases; Fatty Liver; Feeding Behavior; Fructose; Lipids; Male; Ox | 2021 |
Computerized Tomography Based Diagnosis of Visceral Obesity and Hepatic Steatosis is Associated with Low Urine pH.
Topics: Adult; Aged; Fatty Liver; Female; Humans; Hydrogen-Ion Concentration; Intra-Abdominal Fat; Kidney Ca | 2017 |
[The Preliminary Investigation of GLP-1 Receptor Agonist on Liver Steatosis in Obese Mice].
Topics: Animals; Diet, High-Fat; Exenatide; Fatty Liver; Glucagon-Like Peptide-1 Receptor; Insulin Resistanc | 2017 |
Fatty liver index is associated to pulse wave velocity in healthy subjects: Data from the Brisighella Heart Study.
Topics: Adult; Aged; Body Mass Index; Fatty Liver; Female; Healthy Volunteers; Humans; Italy; Linear Models; | 2018 |
Increased Serum Uric Acid over five years is a Risk Factor for Developing Fatty Liver.
Topics: Adult; Body Mass Index; Cohort Studies; Fatty Liver; Female; Humans; Male; Middle Aged; Retrospectiv | 2018 |
Higher levels of serum uric acid influences hepatic damage in patients with non-alcoholic fatty liver disease (NAFLD).
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Analysis of Variance; Biomarkers; Body Mass Index; Chol | 2019 |
Relationship between serum uric acid level and nonalcoholic fatty liver disease in pre- and postmenopausal women.
Topics: Adult; Alanine Transaminase; Asian People; Aspartate Aminotransferases; Body Mass Index; Cholesterol | 2013 |
Serum uric acid and non-alcoholic fatty liver disease in non-diabetic Chinese men.
Topics: Adult; Aged; Asian People; China; Confidence Intervals; Diabetes Mellitus; Fatty Liver; Humans; Line | 2013 |
Dimethyl dimethoxy biphenyl dicarboxylate attenuates hepatic and metabolic alterations in high fructose-fed rats.
Topics: Alanine Transaminase; Animals; Anti-Inflammatory Agents; Antioxidants; Biphenyl Compounds; Blood Glu | 2016 |
Serum uric acid levels and non-alcoholic fatty liver disease in Uyghur and Han ethnic groups in northwestern China.
Topics: Adult; Body Mass Index; China; Fatty Liver; Feeding Behavior; Female; Humans; Hyperuricemia; Life St | 2013 |
Relationship between serum uric acid levels and hepatic steatosis in non-obese postmenopausal women.
Topics: Adult; Aged; Blood Pressure; Body Mass Index; China; Cross-Sectional Studies; Diabetes Mellitus, Typ | 2014 |
Uric acid induces fat accumulation via generation of endoplasmic reticulum stress and SREBP-1c activation in hepatocytes.
Topics: Acetyl-CoA Carboxylase; Animals; Endoplasmic Reticulum Chaperone BiP; Endoplasmic Reticulum Stress; | 2014 |
The significance of serum xanthine oxidoreductase in patients with nonalcoholic fatty liver disease.
Topics: Adult; Anthropometry; Case-Control Studies; Cross-Sectional Studies; Enzyme-Linked Immunosorbent Ass | 2014 |
Patient selection bias may derive from the improper usage of diagnostic methods.
Topics: Fatty Liver; Female; Humans; Postmenopause; Uric Acid | 2014 |
Longitudinal assessment of high blood pressure in children with nonalcoholic fatty liver disease.
Topics: Adolescent; Blood Pressure Determination; Chi-Square Distribution; Child; Child, Preschool; Choleste | 2014 |
Association between serum uric acid and nonalcoholic fatty liver disease.
Topics: Fatty Liver; Humans; Liver; Non-alcoholic Fatty Liver Disease; Risk Factors; Uric Acid | 2016 |
Uric acid regulates hepatic steatosis and insulin resistance through the NLRP3 inflammasome-dependent mechanism.
Topics: AMP-Activated Protein Kinases; Animals; Fatty Liver; Hep G2 Cells; Hepatocytes; Humans; Inflammasome | 2016 |
Models Predictive of Metabolic Syndrome Components in Obese Pediatric Patients.
Topics: Adolescent; Blood Glucose; Blood Pressure; Cardiovascular Diseases; Child; Cross-Sectional Studies; | 2016 |
Uric acid in nonalcoholic fatty liver disease.
Topics: Fatty Liver; Humans; Liver; Non-alcoholic Fatty Liver Disease; Risk Factors; Uric Acid | 2016 |
Fructose surges damage hepatic adenosyl-monophosphate-dependent kinase and lead to increased lipogenesis and hepatic insulin resistance.
Topics: Adenosine Monophosphate; Adenylate Kinase; Allosteric Site; AMP-Activated Protein Kinases; Animals; | 2016 |
[Investigation of metabolic disorders in patients with familial fatty liver disease and their first-degree relatives].
Topics: Blood Glucose; Body Mass Index; China; Family; Fatty Liver; Humans; Hyperglycemia; Metabolic Syndrom | 2016 |
Uncovered issues in the association between uric acid and nonalcoholic fatty liver disease.
Topics: Fatty Liver; Humans; Non-alcoholic Fatty Liver Disease; Risk Factors; Uric Acid | 2016 |
Association of serum uric acid level with non-alcoholic fatty liver disease: a cross-sectional study.
Topics: Adult; Biomarkers; China; Cross-Sectional Studies; Fatty Liver; Female; Humans; Male; Metabolic Synd | 2009 |
Comparison of free fructose and glucose to sucrose in the ability to cause fatty liver.
Topics: Animals; Body Fat Distribution; Chemokine CCL2; Dietary Carbohydrates; Dietary Sucrose; Energy Intak | 2010 |
Association between serum uric acid and non-alcoholic fatty liver disease in Korean adults.
Topics: Adult; Age Factors; Aged; Blood Glucose; Blood Pressure; Body Mass Index; Cities; Exercise; Fatty Li | 2010 |
Genetic covariance between gamma-glutamyl transpeptidase and fatty liver risk factors: role of beta2-adrenergic receptor genetic variation in twins.
Topics: Adult; Biomarkers; Blood Pressure; California; Cross-Sectional Studies; Dyslipidemias; Fatty Liver; | 2010 |
Gout and risk of non-alcoholic fatty liver disease.
Topics: Adult; Aged; Body Mass Index; Cross-Sectional Studies; Fatty Liver; Female; Glomerular Filtration Ra | 2010 |
High serum uric acid increases the risk for nonalcoholic Fatty liver disease: a prospective observational study.
Topics: Adult; Aged; Aged, 80 and over; Fatty Liver; Female; Humans; Male; Middle Aged; Prospective Studies; | 2010 |
Uric acid potentially links fatty liver and high blood pressure.
Topics: Fatty Liver; Humans; Hypertension; Hyperuricemia; Logistic Models; Uric Acid | 2010 |
Hypouricemic therapy: a novel potential therapeutic option for nonalcoholic fatty liver disease.
Topics: Animals; Dietary Fats; Disease Models, Animal; Fatty Liver; Gerbillinae; Humans; Uric Acid | 2010 |
Serum uric acid levels predict incident nonalcoholic fatty liver disease in healthy Korean men.
Topics: Adult; Aging; Alcohol Drinking; Blood Chemical Analysis; Body Mass Index; Fatty Liver; Follow-Up Stu | 2011 |
The relationship between normal serum uric acid and nonalcoholic fatty liver disease.
Topics: Adult; Fatty Liver; Female; Humans; Liver Function Tests; Logistic Models; Male; Middle Aged; Non-al | 2011 |
Association between thyroid function and nonalcoholic fatty liver disease in euthyroid elderly Chinese.
Topics: Aged; Asian People; Body Mass Index; Cross-Sectional Studies; Fatty Liver; Humans; Non-alcoholic Fat | 2011 |
Carotid intima-media thickness is increased not only in non-alcoholic fatty liver disease patients but also in alcoholic fatty liver patients.
Topics: Adult; Alanine Transaminase; Alcohol Drinking; Analysis of Variance; Aspartate Aminotransferases; Bi | 2011 |
Hyperuricemia is associated with histological liver damage in patients with non-alcoholic fatty liver disease.
Topics: Adult; Anthropometry; Biomarkers; Biopsy; Cohort Studies; Fatty Liver; Female; Humans; Hyperuricemia | 2011 |
Hyperuricemia in non-alcoholic fatty liver disease.
Topics: Fatty Liver; Female; Humans; Hyperuricemia; Male; Uric Acid | 2011 |
Uric acid as a surrogate for fructose intake is not supported.
Topics: Diet; Fatty Liver; Female; Humans; Liver; Male; Uric Acid; Vitamin E; Vitamin E Deficiency | 2012 |
Correlation of vitamin E, uric acid, and diet composition with histologic features of pediatric NAFLD.
Topics: Adolescent; Ascorbic Acid; Child; Cross-Sectional Studies; Diet; Dietary Sucrose; Energy Intake; Fat | 2012 |
Hyperuricaemia: another metabolic feature affecting the severity of chronic hepatitis because of HCV infection.
Topics: Biomarkers; Biopsy; Fatty Liver; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Hyperuricemia; M | 2012 |
Relation of uric acid to serum levels of high-sensitivity C-reactive protein, triglycerides, and high-density lipoprotein cholesterol and to hepatic steatosis.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; C-Reactive Protein; Cholesterol, HDL; Fatty Liver; Femal | 2012 |
Renal function-dependent association of serum uric acid with metabolic syndrome and hepatic fat content in a middle-aged and elderly Chinese population.
Topics: Aged; Asian People; Cohort Studies; Cross-Sectional Studies; Fatty Liver; Female; Glomerular Filtrat | 2012 |
Uric acid induces hepatic steatosis by generation of mitochondrial oxidative stress: potential role in fructose-dependent and -independent fatty liver.
Topics: Fatty Liver; Fructose; Hep G2 Cells; Humans; Lipogenesis; Mitochondria; Oxidative Stress; Triglyceri | 2012 |
Elevated serum uric acid levels are associated with non-alcoholic fatty liver disease independently of metabolic syndrome features in the United States: Liver ultrasound data from the National Health and Nutrition Examination Survey.
Topics: Adult; Aged; Aspartate Aminotransferases; Cholesterol, HDL; Cross-Sectional Studies; Fatty Liver; Fe | 2013 |
Uric acid stimulates fructokinase and accelerates fructose metabolism in the development of fatty liver.
Topics: Allopurinol; Animals; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; Enzyme Inhibitors | 2012 |
Counteracting roles of AMP deaminase and AMP kinase in the development of fatty liver.
Topics: Adenylate Kinase; AMP Deaminase; Animals; Carbon-Carbon Double Bond Isomerases; Enzyme Activation; F | 2012 |
Synergistic effect of uricase blockade plus physiological amounts of fructose-glucose on glomerular hypertension and oxidative stress in rats.
Topics: Animals; Beverages; Fatty Liver; Fructokinases; Fructose; Glucose; Hypertrophy; Hyperuricemia; Insul | 2013 |
Leukemoid reaction, hyperuricemia and severe hyperpyrexia complicating a fatal case of acute fatty liver of the alcoholic.
Topics: Alcoholism; Fatty Liver; Fever; Humans; Hyperuricemia; Leukemia; Leukemoid Reaction; Liver Diseases; | 1962 |
[CLINICAL CONTRIBUTION TO THE STUDY OF A NEW SYNTHETIC ANTICHOLESTEREMIC AGENT: BETA-BENZALBUTYRRAMIDE].
Topics: Amides; Anticholesteremic Agents; Arthritis; Arthritis, Rheumatoid; Asthma; Butyrates; Cholelithiasi | 1963 |
Insulin sensitivity and hepatic steatosis in obese subjects with normal glucose tolerance.
Topics: Adult; Alanine Transaminase; Blood Glucose; Body Mass Index; Cholesterol; Cohort Studies; Fatty Live | 2004 |
Gallstone disease in non-alcoholic fatty liver: prevalence and associated factors.
Topics: Age Factors; Apolipoproteins B; Biopsy; Cholecystolithiasis; Cholesterol; Fatty Liver; Female; Gallb | 2005 |
Uric acid and anti-TNF antibody improve mitochondrial dysfunction in ob/ob mice.
Topics: Animals; Antibodies; Blotting, Western; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; F | 2006 |
Ultrasonographic and biochemical evaluation of visceral obesity in obese women with non-alcoholic fatty liver disease.
Topics: Adult; Age Factors; Alanine Transaminase; Aspartate Aminotransferases; Blood Glucose; Blood Pressure | 2007 |
An Experimental Syndrome of Fatty Liver, Uric Acid Kidney Stones, and Acute Pancreatic Necrosis Produced in Dogs by Exclusive Feeding of Bacon.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dogs; Doxorubicin; Fatty Liver; | 1948 |
Fatty liver and uric acid levels predict incident coronary heart disease but not stroke among atomic bomb survivors in Nagasaki.
Topics: Aged; Coronary Disease; Fatty Liver; Female; Humans; Japan; Male; Middle Aged; Nuclear Weapons; Pros | 2007 |
Pre-eclampsia: excessive activation of a G protein-associated receptor?
Topics: Arachidonic Acids; Calcium; Endothelium, Vascular; Fatty Liver; Female; GTP-Binding Proteins; Humans | 1995 |
Relationship between serum leptin and fatty liver in Japanese male adolescent university students.
Topics: Adipose Tissue; Adolescent; Adult; Alanine Transaminase; Analysis of Variance; Aspartate Aminotransf | 1999 |
Metabolism in two breeds of geese with moderate or large overfeeding induced liver-steatosis.
Topics: Animals; Blood Glucose; Body Composition; Body Weight; Eating; Fatty Liver; Food Deprivation; Geese; | 2000 |
Fasting insulin and uric acid levels but not indices of iron metabolism are independent predictors of non-alcoholic fatty liver disease. A case-control study.
Topics: Case-Control Studies; Fatty Liver; Female; Humans; Insulin; Insulin Resistance; Logistic Models; Mal | 2002 |
[Gout in young subjects].
Topics: Adolescent; Adult; Age Factors; Angina Pectoris; Back Pain; Diabetes Complications; Fatty Liver; Fem | 1977 |
[Side effects of sugar substitutes].
Topics: Administration, Oral; Diarrhea; Fatty Liver; Glucose; Glycerol; Humans; Insulin; Insulin Secretion; | 1977 |
[Alcoholism and anesthesia problems].
Topics: Alcoholism; Anesthesia; Brain; Ethanol; Fatty Liver; Humans; Lactates; Liver; Liver Cirrhosis; Uric | 1979 |
[The "alcohol-syndrome" from internal medical view (author's transl)].
Topics: Adult; Age Factors; Alcoholism; Anxiety; Fatty Liver; Humans; Hyperlipidemias; Hypertension; Obesity | 1977 |
Anesthetic biotransformation and renal function in obese patients during and after methoxyflurane or halothane anesthesia.
Topics: Adjuvants, Anesthesia; Adult; Anesthesia, Inhalation; Biopsy, Needle; Biotransformation; Fatty Liver | 1975 |
[Acute fatty liver of pregnancy. Diagnostic value of hyperuricemia in the pre-jaundice stage].
Topics: Acute Disease; Adult; Fatty Liver; Female; Humans; Pregnancy; Pregnancy Complications; Uric Acid | 1988 |
[Changes in metabolic parameters, especially in fat metabolism, in chronic alcoholics during clinical alcohol deficiency].
Topics: Adult; Alcoholism; Aspartate Aminotransferases; Bile Acids and Salts; Bilirubin; Biopsy; Blood Prote | 1972 |
[8 years of SGPT screening at the District Institute for Blood Donation and Transfusion Services in Karl-Marx-Stadt].
Topics: Adult; Alanine Transaminase; Biopsy; Blood Donors; Clinical Enzyme Tests; Diabetes Mellitus; Fatty L | 1973 |
Hypouricemia and hyperuricosuria in Laennec cirrhosis.
Topics: Alcoholism; Bilirubin; Creatinine; Fatty Liver; Humans; Kidney Function Tests; Kidney Tubules; Liver | 1974 |
Interference by urate in the determination of plasma glucose.
Topics: Animals; Blood Glucose; Chickens; Fatty Liver; Female; Kidney Diseases; Male; Methods; Poultry Disea | 1974 |
[Changes between 1948 and 1970 in the epidemiology and clinical features of primary gout].
Topics: Adult; Age Factors; Aged; Alcohol Drinking; Blood Protein Disorders; Diabetes Complications; Fatty L | 1973 |
The effect of forced feeding and of dietary protein level on enzymes associated with digestion, protein and carbohydrate metabolism in geese.
Topics: Amylases; Animal Feed; Animals; Arginase; Blood Urea Nitrogen; Chymotrypsin; Dietary Carbohydrates; | 1973 |
Relationship between hepatic morphology and clinical and biochemical findings in morbidly obese patients.
Topics: Adipose Tissue; Adolescent; Adult; Age Factors; Carbohydrate Metabolism; Cell Nucleus; Fatty Liver; | 1973 |
Surgical treatment of obesity.
Topics: Blood Sedimentation; Calcium; Cholesterol; Diarrhea; Fatty Liver; Folic Acid; Humans; Ileostomy; Iro | 1973 |
[Gout, diabetes mellitus and fatty liver].
Topics: Adult; Arteriosclerosis; Body Weight; Diabetes Complications; Fatty Liver; Female; Gout; Humans; Hyp | 1972 |
[Uric acid abnormalities in juveniles. Peculiarities of the clinical picture].
Topics: Adolescent; Adult; Diabetes Complications; Diagnosis, Differential; Fatty Liver; Gout; Humans; Hyper | 1971 |
[Diabetes mellitus, hyperlipemia, fatty liver, hypertension in primary gout and their influencing by benzbromaronum].
Topics: Adult; Benzofurans; Blood Glucose; Blood Sedimentation; Colchicine; Creatinine; Diabetes Mellitus; E | 1970 |
[Alterations of lipid metabolism in primary gout and hyperuircemia].
Topics: Adult; Aged; Blood Glucose; Cholesterol; Diabetes Mellitus; Fatty Acids; Fatty Acids, Nonesterified; | 1971 |
[Gout in young patients].
Topics: Adolescent; Adult; Age Factors; Diabetes Complications; Fatty Liver; Gout; Humans; Hyperlipidemias; | 1971 |
[Liver pathology in gout].
Topics: Adult; Biopsy; Blood Glucose; Blood Protein Electrophoresis; Body Weight; Cholesterol; Diabetes Comp | 1971 |